2023
DOI: 10.3389/fgene.2023.1107787
|View full text |Cite
|
Sign up to set email alerts
|

Tenascin-X as a causal gene for classical-like Ehlers-Danlos syndrome

Abstract: Tenascin-X (TNX) is an extracellular matrix glycoprotein for which a deficiency results in a recessive form of classical-like Ehlers-Danlos syndrome (clEDS), a heritable connective tissue disorder with hyperextensible skin without atrophic scarring, joint hypermobility, and easy bruising. Notably, patients with clEDS also suffer from not only chronic joint pain and chronic myalgia but also neurological abnormalities such as peripheral paresthesia and axonal polyneuropathy with high frequency. By using TNX-defi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
1

Relationship

2
4

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 64 publications
0
2
0
Order By: Relevance
“…Expression of tenascin X and collagen VI also appears to be coordinately regulated ( Minamitani et al, 2004b ) and they collaborate in driving the formation of heterotypic fibrils containing collagen I ( Minamitani et al, 2004a ). Tenascin X deficiency also causes a spectrum of mEDS-like disorders that mimic the phenotype of collagen VI related myopathies ( Burch et al, 1997 ; Brisset et al, 2020 ; Marino et al, 2022 ; Okuda-Ashitaka and Matsumoto, 2023 ).…”
Section: Hypothesis and Discussion: Genetic And Biochemical Evidence ...mentioning
confidence: 99%
“…Expression of tenascin X and collagen VI also appears to be coordinately regulated ( Minamitani et al, 2004b ) and they collaborate in driving the formation of heterotypic fibrils containing collagen I ( Minamitani et al, 2004a ). Tenascin X deficiency also causes a spectrum of mEDS-like disorders that mimic the phenotype of collagen VI related myopathies ( Burch et al, 1997 ; Brisset et al, 2020 ; Marino et al, 2022 ; Okuda-Ashitaka and Matsumoto, 2023 ).…”
Section: Hypothesis and Discussion: Genetic And Biochemical Evidence ...mentioning
confidence: 99%
“…In addition, pain is a sever clinical manifestation of EDS patients, and approximately 90% of EDS patients complain of chronic pain 6 8 . EDS patients suffer from chronic neuropathic pain, generalized body pain, gastrointestinal pain, headache, dysmenorrhea, and fatigue, in addition to connective tissues-related pain such as joint pain, soft-tissue pain, and dislocations 6 , 7 . TNX-deficient EDS patients complain of chronic pain such as chronic joint pain, myalgia, abdominal pain, fatigue, paresthesia, and axonal polyneuropathy 3 , 5 .…”
Section: Introductionmentioning
confidence: 99%